The DIAN‐TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model-Reference-Cited by-同舟云学术

The DIAN‐TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model

Published:2016-08-29 Issue:1 Volume:13 Page:8-19
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Bateman Randall J.¹,Benzinger Tammie L.²,Berry Scott³,Clifford David B.¹,Duggan Cynthia¹,Fagan Anne M.¹,Fanning Kathleen¹,Farlow Martin R.⁴,Hassenstab Jason¹,McDade Eric M.¹,Mills Susan¹,Paumier Katrina¹,Quintana Melanie³,Salloway Stephen P.⁵,Santacruz Anna¹,Schneider Lon S.⁶,Wang Guoqiao⁷,Xiong Chengjie⁷,

Affiliation:

1. Department of Neurology Washington University in St Louis St Louis MO USA

2. Department of Radiology Washington University in St Louis St Louis MO USA

3. Berry Consultants Austin TX USA

4. Indiana Alzheimer Disease Center Indiana University Indianapolis IN USA

5. Memory and Aging Program, Butler Hospital Brown Medical School Providence RI USA

6. Alzheimer's Disease Research Center Keck School of Medicine of the University of Southern California Los Angeles CA USA

7. Department of Biostatistics Washington University in St Louis St Louis MO USA

Funder

Alzheimer's Association

Roche

Avid Radiopharmaceuticals

National Institute on Aging

Deutsches Zentrum für Neurodegenerative Erkrankungen

BrightFocus Foundation

Amgen

AstraZeneca

Biogen

Eisai

Pfizer

Sanofi

Anonymous Foundation

GHR Foundation

DIAN-TU Pharma Consortium

Eli Lilly

NIH

Cogstate

Bracket

German Center for Neurodegenerative Diseases

IBL International

Forum

Janssen AIP

Sanofi-Aventis

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2016.07.005

Reference73 articles.

1. National estimates of the prevalence of Alzheimer's disease in the United States

2. Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease

3. Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis

4. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

5. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Cited by 224 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases;Neuro-Oncology Practice;2024-01-04

2. Novel avenues of tau research;Alzheimer's & Dementia;2024-01-03

3. Landscape of Phase II Trials in Alzheimer’s Disease;Journal of Alzheimer's Disease;2023-11-07

4. Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer disease;2023-11-01

5. T1 and FLAIR signal intensities are related to tau pathology in dominantly inherited Alzheimer disease;Human Brain Mapping;2023-10-23